coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Horizon PCN, Bury (LAD) · Health Inequalities Profile

    PCN U49525 · NHS Greater Manchester Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    91,722

    Registered population

    59.5% aged 18–64

    21.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    15.5%

    Ethnic minority (non-White)

    10.4% Asian · England 9.6%

    29.8%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~26,532

    Core20 residents (est.)

    Resident basis; registered basis ~28,561 · see page 3

    15,381

    Hypertension register

    +5.96% in 3 yrs · England +5.60%

    1,118

    SMI register

    44.7% of Bury (LAD)'s

    2,101

    COPD register

    Reviews -0.64% in 3 yrs

    Forecast to 2030

    17,459

    Hypertension patients, 2030

    +2,078 on today

    70.9%

    QRISK ≥20% on statins, 2030

    +3.60pp over 3 yrs

    5.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    81.4%
    Smoking support and diabetes control lag England.

    Smoking support fell 15.6 pp to 81.4% (England 94.2%, +0.1 pp) and non-frail diabetes HbA1c control is 53.0% (England 57.4%), which may reflect recall.

    2,153
    Unreviewed asthma scale and youth prescribing gap.

    An estimated 2,153 asthma patients lack an annual review, while 5-19 prescribing is 2,311 per 1,000 (England 1,488) and 6-19 second-hand smoke recording is.

    75.9%
    Breast screening coverage exceeds local and national rates.

    Breast screening coverage for ages 53 to 70 is 75.9% after a +7.4% 3-year change (2023 to 2024), above Bury (73.8%) and England (69.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A 21.1% older population and 39 care homes may elevate primary care demand

    Horizon PCN has an older registered population across 91,722 patients: 21.1% (19,385) are aged 65+, above Bury (LAD) (17.6%), NHS Greater Manchester ICB (14.9%) and England (17.9%). The 0-17 cohort is 19.4% and aged 18-64 is 59.5%. Projected list growth to 2030 is 0.7% (Bury (LAD) 0.7%, ICB 1.6%, England 2.3%), with unverified methodology. Based on Census usual residents rather than GP lists, 84.5% are White and 10.4% Asian or Asian British (Bury (LAD) 10.6%, ICB 13.6%, England 9.6%), reaching 20.3% at Ribblesdale Medical Practice and 19.4% at Peel Gps.

    Age profile

    0–1719.4%
    18–6459.5%
    65+21.1%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White84.5%
    Asian10.4%
    Mixed2.2%
    Black1.7%
    Other1.2%

    Older people · falls rows are Bury (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bury LA)2,1392,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bury LA)1,0511,0219552024/25
    Falls deaths, all ages, per 100,000 (Bury LA)21.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 registered share is 29.8% and spans 56.6 percentage points across practices

    Average IMD decile is 5.2 (Bury (LAD) 5.2 decile, NHS Greater Manchester Integrated Care Board 4.5 decile, England 5.5 decile). Core20 registered share is 29.8% (Bury (LAD) 27.9%, NHS Greater Manchester Integrated Care Board 40.7%, England 21.0%). Weighted practice share is 31.1% (a 1.34 percentage point reconciliation difference). Concentration spans 56.6 pp: Peel Gps has 59.17% (5,723 estimated patients) and Ribblesdale Medical Practice 50.77% (3,687), while Tower Family Healthcare holds 13,241 estimated patients (27.67% share). Delivery must balance intensive outreach in high-concentration practices with high-volume recall at larger lists.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Peel Gps59.2% · 5,723 patients
    Ribblesdale50.8% · 3,687 patients
    Red Bank38.6% · 3,438 patients
    Tower Family27.7% · 13,241 patients
    Woodbank23.7% · 1,667 patients
    Mile Lane12.2% · 666 patients
    Garden City2.5% · 139 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,118

    SMI register

    1.21% recorded prevalence

    533

    Learning disability register

    0.58% recorded prevalence

    39

    Care homes, 1,163 beds

    In the PCN catchment

    9.4%

    Provide unpaid care

    Bury (LAD), Census 2021

    The PCN records 1,118 patients on its severe mental illness register (1.2%, above England's 1.0%) and 533 on its learning disability register (0.6%, matching England). The catchment includes 39 care homes with 1,163 beds, though beds do not confirm GP occupancy. Higher severe mental illness prevalence may indicate elevated physical-health monitoring demand, which practice-level check audits could test.

    Severe mental illness: physical health checks

    SMI prevalence is 1.2% (1,118 patients). Annual checks cover 76.3% for blood pressure and 76.3% for BMI, both trailing England (83.4% and 82.1%). Smoking cessation support fell 15.6 pp over 2023 to 2025 to 81.4% (England +0.1 pp, 94.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    15,381

    Hypertension register

    +5.96%

    Register growth, 3 yrs

    Bury (LAD) +6.10% · England +5.60%

    +0.44pp

    BP control, under 80

    ≤140/90 · +2.60pp aged 80+

    +2,078

    More patients by 2030

    Forecast 17,459 (18.66%)

    Hypertension case-finding and control

    Hypertension prevalence is 16.6% (15,381 patients), above Bury (LAD) (15.2%), NHS Greater Manchester Integrated Care Board (14.4%), and England (15.2%). For patients aged under 80 with hypertension, blood pressure control within the last 12 months is 67.3%, trailing Bury (LAD) (67.7%), NHS Greater Manchester Integrated Care Board (68.6%), and England (67.8%). Three-year growth (+0.7%, 2023 to 2025) lagged Bury (LAD) (+6.4%) and England (+3.2%). Observation periods for prevalence are not supplied. Lower blood pressure control among younger hypertensive patients may indicate a need to audit recall and titration routines against benchmark performance.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid-lowering therapy stand at 63.0%, trailing Bury (LAD) (64.2%), NHS Greater Manchester Integrated Care Board (67.0%), and England (63.6%). Patients aged 40+ with diabetes and no CVD history treated with a statin reach 71.0% (England 73.2%). Gaps may reflect review patterns, which audit could test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026174,417£1.90£1.94£1.86£331,392
    Cardiovascular (all), 2025233,849£3.42£3.15£3.33£799,764

    Prescribing for lipid-regulating drugs in 2026 totaled 174,417 items at £1.90 per item (£331,392 spend), compared to £1.91 in Bury (LAD), £1.94 in NHS Greater Manchester Integrated Care Board, and £1.86 in England. The PCN spends £6,977 more than at England's unit cost, across 174,417 items. Unit cost differences do not establish efficiency or formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +38.57%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.68%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.3% (6,384 patients; England 6.6%). Annual reviews rose +38.6% over 2023 to 2025 (England +4.4%) to 66.3% (England 65.7%), leaving an estimated 2,153 register patients unreviewed. Prescribing for ages 5 to 19 is 2,311 items per 1,000 (England 1,488), while second-hand smoke recording for ages 6 to 19 is 69.1% (England 78.8%). COPD prevalence is 2.3% (2,101 patients; England 1.9%), but the register fell 3.0% over 2023 to 2025 (England +2.6%). High youth prescribing may reflect exposure risks, which review audits could test.

    Cancer register and children's immunisation

    Cancer prevalence is 4.7% (4,345 patients; England 3.8%). In Q1 2025/26 supplementary data, MMR dose 1 coverage at 24 months was 85.0% (England 88.3%). By age five, MMR dose 1 reached 95.7% (England 91.7%), but dose 2 dropped 9.1 pp to 86.6% (England 82.8%). The gap between first and second dose at age five may reflect timing of pre-school recalls, which practice-level call audits could clarify.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.6%

    England 91.0%

    6-in-1 complete primary course at 24 months91.6%

    England 92.2%

    MMR dose 1 at 24 months85.0%

    England 88.3%

    MMR dose 2 at age 586.6%

    England 82.8%

    4-in-1 pre-school booster at age 586.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In NHS Greater Manchester ICB, 55.6% of cancers were diagnosed at stage 1 or 2 in 2022 (England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028. Reaching that ambition would require about 2,270 extra early-stage cases annually across the ICB. While Horizon PCN records 68.1% cervical screening coverage (England 66.8%), practice coverage varies, dropping to 55.3% at Peel Gps and 59.2% at Ribblesdale Medical Practice. Early-stage diagnosis data was not captured at PCN level and does not measure PCN performance. Lower practice-level screening coverage may delay early detection for registered cohorts, which recall audits could test.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For July 2026 (provisional), Bolton NHS Foundation Trust achieved 69.7% on the cancer 62-day referral to treatment standard, trailing England (71.2%) and remaining 15.3 pp below the 85.0% standard. NHS Greater Manchester ICB reached 75.7% (9.3 pp below the standard). Conversely, Bolton NHS Foundation Trust met the 28-day faster diagnosis standard at 80.5%, exceeding the 75.0% standard (ICB 79.5%, England 79.3%). These operational waiting times reflect acute trust performance and do not establish PCN-level patient delays. System-level treatment delays highlight the need for robust safety-netting following urgent referrals.

    Pathways within standard (%)BoltonNorthern Care AllianceManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4875.2080.0679.5379.32
    31-day treatment (96%)96.5094.5492.5496.4992.50
    62-day referral to treatment (85%)69.6678.6572.8575.7371.16
    Diagnostic waits over 6 weeks (%)BoltonNorthern Care AllianceManchesterEngland
    MRI2.055.0911.6821.40
    CT19.404.1014.669.92
    Echocardiography3.4831.484.9128.48
    Colonoscopy1.3340.044.5130.83
    Gastroscopy2.0636.4829.3529.02
    All 15 DM01 tests15.7815.718.9823.14
    Community services activityBury residentsGreater Manchester ICB
    Care contacts58,875573,310
    Referrals7,43594,470
    Patients with a contact16,745183,535

    Community services (residents of Bury), Jun 2026 (provisional). In June 2026 (provisional), community contacts with adults aged 65+ accounted for 43.7% of all contacts for Bury borough residents (25,735 of 58,875). These figures capture borough-wide resident activity and do not represent PCN-specific service delivery. Heavy borough community contact volumes among older adults indicate substantial local intermediate-care reliance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF clinical-domain achievement was 98.4% at Woodbank Surgery and 100.0% at Garden City Medical Centre, compared to 97.1% for England. The range across captured practices in QOF vaccination and immunisation-domain achievement was 60.3 pp. Woodbank Surgery achieved 15.6%, whereas Garden City Medical Centre achieved 76.0% (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Garden City1022.576.4%71.7%91.8%
    Peel Gps9759.259.6%66.4%80.2%
    Mile Lane10312.248.8%63.7%73.2%
    Ribblesdale9950.860.5%65.4%70.2%
    Tower Family11827.748.1%71.1%66.9%
    Red Bank10038.628.0%58.5%66.6%
    Woodbank Surgery9023.744.4%79.7%60.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBury (LAD)AssetPCNBury (LAD)
    Care homes (catchment)39 (1,163 beds)n/aSchools (catchment)120n/a
    Children's centres58Places of worship75107
    Libraries812Primary schools (LA maintained)2225
    Primary academies2433Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and youth smoke reviews

    Asthma reviews reached 66.3% (England 65.7%), leaving an estimated 2,153 of 6,384 patients unreviewed; 5-19 prescribing is 2,311 per 1,000 (England 1,488) and 6-19 smoke recording is 69.1% (England 78.8%). For discussion: practices could run a single-template recall for unreviewed asthma patients, pairing inhaler prescribing checks with second-hand smoke recording. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Cardiometabolic, SMI and smoking recall

    Non-frail diabetes HbA1c control is 53.0% (2,740 of 5,171 in 2024/25; England 57.4%; 3-year change -1.6% vs England +4.4%), SMI BP checks are 76.3% (England 83.4%), and smoking support fell 15.6 pp to 81.4% (England +0.1 pp, 94.2%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Learning disability register validation

    Learning disability prevalence is 0.6% (533 of 91,722 patients); 3-year growth (+1.4%, 2023 to 2025) trailed Bury (LAD) (+3.6%) and England (+5.4%), giving a modelled range of +6 to +13 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult anticipatory care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Mental health physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma and youth smoke reviews (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Cardiometabolic, SMI and smoking recall (p12)Diabetes without frailty: HbA1c at or below 58 mmol/mol · IFCC-HbA1c <= 58 mmol/mol in patients with diabetes without frailty (denominator incl. PCAs) · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15